What is Velius?
Velius, LLC operates as a fully integrated biopharmaceutical entity dedicated to the advancement of prescription and over-the-counter dermatological products. The company's portfolio spans pharmaceuticals for conditions such as aging, scarring, and oncology, positioning it at the intersection of healthcare and biotechnology. Velius's core mission revolves around pioneering research and the adoption of novel technologies to deliver effective skin treatment solutions to both medical professionals and consumers.
How much funding has Velius raised?
Velius has raised a total of $135K across 1 funding round:
Debt
$135K
Debt (2021): $135K with participation from PPP
Key Investors in Velius
PPP
Public-Private Partnership
What's next for Velius?
With the recent strategic investment, Velius is poised to accelerate its development pipeline and expand its market reach. The substantial backing suggests a strong confidence in the company's therapeutic candidates and its long-term growth strategy. Future endeavors will likely focus on clinical trial progression, regulatory approvals, and the commercialization of its innovative product offerings, further solidifying its position in the competitive biopharmaceutical landscape.
See full Velius company page
